Brello GLP-1 Program: Medications, Access, and Pricing Explained

Welcome to the PlexusDx Education Hub, where we unpack GLP-1 therapies, weight-management protocols, and the genetic factors sitting underneath every metabolic decision. Browse all Peptides & GLP-1 education

What follows is an independent editorial review. PlexusDx holds no commercial relationship with Brello or its parent company, and nothing here involves affiliate links or paid placement.

Search interest in Brello often centers on one question: what does its GLP-1 program actually give you access to? This review maps the offering — the medications it can route, the steps to a first fill, and what the program fee covers. It is fair-balance context, not a purchase recommendation, and reflects the landscape as of April 2026.

Brello in the GLP-1 landscape

Brello (Brello Health) is one of many telehealth-plus-pharmacy operators competing for GLP-1 patients. In this model a licensed provider evaluates you remotely, then writes a prescription that flows either to a retail pharmacy for an FDA-approved brand product or to a 503A compounding pharmacy for compounded semaglutide or tirzepatide. Program details and pricing live on Brello's own site — look up the current URL when you read this.

The medications a GLP-1 program can dispense

Any legitimate GLP-1 offering is built on the same underlying compound class: GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide, plus the GIP/GLP-1 dual agonist tirzepatide. The published evidence base includes STEP (semaglutide for weight management, The New England Journal of Medicine, 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024). Trial populations and endpoints differ, and individual outcomes vary.

Getting started: intake to first shipment

The typical sequence is consistent across telehealth GLP-1 programs. You complete an intake covering weight, medical history, and current medications; a licensed clinician reviews it and, if you qualify, issues a prescription; that script routes to a retail or compounding pharmacy for fulfillment; and follow-up visits support titration and side-effect management. Where programs diverge is provider type (physician versus NP or PA), pharmacy partner, and how the subscription is structured.

What a program fee covers

Brello posts its own pricing, and the total shifts with the product chosen, the subscription tier, and whether you receive an FDA-approved brand or a compounded alternative. Across the telehealth GLP-1 market, monthly totals as of April 2026 span roughly $200 to $700 or more, with wide variance. Confirm the current figure on Brello's official site before committing — these numbers move often.

The genetics of GLP-1 that a prescription skips

What a telehealth program does not examine is the genetic terrain a GLP-1 compound acts on. Variants in FTO (the fat-mass and obesity-associated gene), GLP1R (the GLP-1 receptor gene that every GLP-1 compound targets), MC4R (a melanocortin receptor central to satiety), and TCF7L2 (a transcription factor tied to glucose control and GLP-1 secretion) describe your baseline metabolic biology. They are pathway-level markers — they do not predict how you will respond to a specific drug, but they characterize the ground a clinician is prescribing into.

PlexusDx makes semaglutide and tirzepatide available through its Weight Management Protocols — offered as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. The difference is what comes first. The Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights — including FTO, GLP1R, MC4R, and TCF7L2 — so you understand your appetite-regulation and energy-balance biology before you start. That is the test before you invest approach, turning guesswork into an informed conversation with your provider.

Not affiliated: PlexusDx has no affiliation or commercial relationship with Brello or any company named in this article.

Related reading on PlexusDx: What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist, GLP 1 Drugs.

Disclaimer: This is educational content. PlexusDx is not affiliated with Brello and has no commercial relationship with the companies reviewed; it offers semaglutide and tirzepatide through its own Weight Management Protocols, and this review simply compares approaches across the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related pathways and does not predict response to any specific medication. Speak with a qualified healthcare provider before starting any peptide protocol.

See how PlexusDx does it differently: explore the Weight Management Protocols for semaglutide and tirzepatide with genetic context, or begin upstream and take the Precision Peptide Genetic Test to map your GLP-1 pathway first.

Frequently Asked Questions

Which GLP-1 medications can a Brello-style program provide?

Programs in this model generally work with GLP-1 receptor agonists like semaglutide and dual agonists like tirzepatide, dispensed as either FDA-approved brand products through retail pharmacies or compounded formulations through 503A pharmacies. The exact menu depends on the operator, so verify current offerings on the brand's own website.

Does Brello dispense brand-name or compounded GLP-1s?

Telehealth operators may route to a retail pharmacy for FDA-approved brand products or to a 503A compounding pharmacy for compounded semaglutide or tirzepatide. Which pathway applies depends on eligibility, availability, and program design. Check Brello's official site to confirm how its dispensing works before enrolling.

How does the Precision Peptide Genetic Test relate to a GLP-1 program?

It does not replace or predict any program's results. The test analyzes pathway-level variants in FTO, GLP1R, MC4R, and TCF7L2 that shape baseline GLP-1 biology — upstream context that applies no matter which telehealth service ultimately writes the prescription.

How is the PlexusDx GLP-1 approach different from Brello's?

PlexusDx pairs semaglutide and tirzepatide with the Precision Peptide Genetic Test, so a protocol starts with pathway-level genetic insight rather than an intake form alone. That upstream data layer is what most telehealth-only programs, Brello included, do not provide alongside the medication.

Keep exploring the PlexusDx Education Hub. Browse all Peptides & GLP-1 education